Wingesic Plus Tablet is a combination analgesic formulation containing Chlorzoxazone 250 mg, Diclofenac 50 mg, and Paracetamol 325 mg, designed for the management of musculoskeletal pain and inflammation. Chlorzoxazone acts as a centrally acting muscle relaxant, alleviating muscle spasms by depressing nerve impulses in the spinal cord and subcortical areas of the brain. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), provides potent anti-inflammatory, analgesic, and antipyretic effects by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing prostaglandin synthesis involved in pain and inflammation. Paracetamol contributes additional analgesic and antipyretic activity through central inhibition of prostaglandin synthesis, enhancing overall pain relief. Wingesic Plus is indicated for the symptomatic treatment of acute musculoskeletal conditions such as strains, sprains, back pain, and other soft tissue injuries where muscle spasm and inflammation coexist. It should be used with caution in patients with hepatic, renal, or gastrointestinal impairment and is contraindicated in individuals with known hypersensitivity to any of its components. The combination therapy offers a multimodal approach to pain management, improving patient comfort and functional recovery. Dosage and duration should be as prescribed by a healthcare professional to minimize adverse effects and ensure optimal therapeutic outcomes.